Copper, ceruloplasmin and superoxide dismutase (SOD) in amyotrophic lateral sclerosis

Pharmacology and Toxicology

Volumn 87, Issue 3, 2000, Pages 126-130

  Tórsdóttir, Gudlaug ^a,b   Kristinsson, Jakob ^a   Gudmundsson, Grétar ^c   Snaedal, Jón ^b   Jóhannesson, Torkell ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

^b Reykjavik City Hospital   (Iceland)

^c LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; COPPER; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; MOTONEURON; NERVE CELL NECROSIS; OXIDATION; PRIORITY JOURNAL;

EID: 0033803619     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0901-9928.2000.870305.x     Document Type: Article

References (23)

1. Bergeron, C.: Oxidative stress: its role in the pathogenesis of amyotrophic lateral sclerosis. J. Neurol Sci. 1995, 129 (Suppl.), 81-84.
2. Bogdanov, M. B., L. E. Ramos, Z. Xu & M. F. Beal: Elevated "hydroxyl radical" generation in vivo in an animal model of amyotrophic lateral sclerosis. J. Neurochem. 1998, 71, 1321-1324.
3. Borchelt, D. R., M. Guarnieri, P. C. Wong, M. K. Lee, H. S. Slunt, Z.-S. Xu, S. S. Sisodia, D. L. Price & D. W. Cleveland: Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect wilde-type subunit function. J. Biol. Chem. 1995, 270, 3234-3238.
4. Boyett, J. D., H. P. Lehmann & M. F. Beeler: Automated assay of ceruloplasmin by kinetic analysis of o-dianisidine oxidation. Acta Clin. Chem. 1976, 69, 233-241.
5. Brooks, B. R.: El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J. Neurol. Sci. 1994, 124 (Suppl.), 96-107.
6. Domzal, T. & B. Radzikowska: Ceruloplasmin and copper in the serum of patients with amyotrophic lateral sclerosis (ALS). Neurol. Neurochir. Pol. 1983, 17, 343-346 (Polish with English abstract).
7. Eum, W. S. & J. H. Kang: Release of copper ions from the familial amyotrophic lateral sclerosis-associated Cu, Zn-superoxide dismutase mutants. Mol. Cells 1999, 9, 110-114.
8. Gurney, M. E., H. Pu, A. Y. Chiu, M. C. D. Canto, C. Y. Polchow, D. D. Alexander, J. Caliendo, A. Hentati, Y. W. Kwon, H.-X. Deng, W. Chen, P. Zhai, R. L. Sufit & T. Siddique: Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994, 264, 1772-1775.
9. Hottinger, A. E, E. G. Fine, M. E. Gurney, A. D. Zum & P. Aebischer: The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis. Eur. J. Neurosci. 1997, 9, 1548-1551.
10. Jones, C. T., D. J. H. Brock, A. M. Chancellor, C. P. Warlow & R. J. Swingler: Cu/Zn superoxide dismutase (SOD1) mutations and sporadic amyotrophic lateral sclerosis. Lancet 1993, 342, 1050-1051.
11. Kapaki, E., C. Zournas, G. Kanias, T. Zambelis, A. Kakami & C. Papageorgiou: Essential trace element alterations in amyotrophic lateral sclerosis. J. Neurol. Sci. 1997, 147, 171-175.
12. Klivenyi, P., R. J. Ferrante, R. L. Matthews, M. B. Bogdanov, A. M. Klein, O. A. Andreassen, G. Mueller, M. Wermer, R. Kaddurah-Daouk & M. F. Beal: Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nature Medicine 1999, 5, 347-350.
13. Klomp, L. W. J. & J. D. Gitlin: Expression of the ceruloplasmin gene in the human retina and brain: implication for a pathogenic model in aceruloplasminemia. Hum. Mol. Gen. 1996, 5, 1989-1996.
14. Louvel, E., J. Hugon & A. Doble: Therapeutic advances in amyotrophic lateral sclerosis. TiPS 1997, 18, 196-203.
15. Mzhel'skaia, T. I., I. A. Zavalishin, I. A. Ivanova-Smolenskaia, E. G. Larskii, V. V. Basevich, E. D. Markova & A. S. Niiazbekova: Ceruloplasmin activity in the blood during progressive diseases of the central nervous system. Lab. Delo 1989, 11, 12-6 (Polish text with English abstract).
16. Nebot, C., P. Moutet, P. Huet, J. Z. Xu, J. C. Yadan & J. Chaudiere: Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic cathechol. Anal. Biochem. 1993, 214, 442-451.
17. Reaume, A. G., J. L. Elliott, E. K. Hoffman, N. W. Kowall, R. J. Ferrante, D. F. Siwek, H. M. Wilcox, D. G. Flood, M. F. Beal, R. H. Brown, R. W. Scott & W. D. Snider: Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genetics 1996, 13, 43-47.
18. Robberecht, W., P. Sapp, M. K. Viaene, D. Rosen, D. McKenna-Yasek, J. Haines, R. Horvitz, P. Theys & R. Brown: Cu/Zn superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 1994, 62, 384-387.
19. Rothstein, J. D., M. Van Kammen, A. I. Levery, L. J. Martin & R. W. Kuncl: Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol 1995, 38, 73-84.
20. Snaedal, J., J. Kristinsson, S. Gunnarsdóttir, Á. Ólafsdóttir, M. Baldvinsson & T. Jóhannesson: Copper, ceruloplasmin and superoxide dismutase in patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 1998, 9, 239-242.
21. Sokal, R. R. & F. J. Rohlf: In: Biometry. The principles of statistics in biological research. V. H. Freeman & Co., New York, N.Y., USA, 1981, pp. 411, 716-721.
22. Tórsdóttir, G. J. Kristinsson, S. Sveinbjörnsdóttir, J. Snaedal & T. Jóhannesson: Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease. Pharmacology & Toxicology 1999, 85, 239-243.
23. Volterra, A., D. Trotti, C. Tromba, S. Floridi & G. Racagni: Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 1994, 14, 2924-2932.